OA11997A - Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins. - Google Patents

Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins. Download PDF

Info

Publication number
OA11997A
OA11997A OA1200200024A OA1200200024A OA11997A OA 11997 A OA11997 A OA 11997A OA 1200200024 A OA1200200024 A OA 1200200024A OA 1200200024 A OA1200200024 A OA 1200200024A OA 11997 A OA11997 A OA 11997A
Authority
OA
OAPI
Prior art keywords
leu
ala
val
gly
arg
Prior art date
Application number
OA1200200024A
Other languages
English (en)
Inventor
Kim Jonelle Stutzman-Engwall
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11997A publication Critical patent/OA11997A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA1200200024A 1999-08-12 2000-07-19 Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins. OA11997A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins

Publications (1)

Publication Number Publication Date
OA11997A true OA11997A (en) 2006-04-18

Family

ID=23470234

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200024A OA11997A (en) 1999-08-12 2000-07-19 Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins.

Country Status (37)

Country Link
US (8) US6248579B1 (fr)
EP (1) EP1200605B1 (fr)
JP (2) JP3688640B2 (fr)
KR (1) KR100486006B1 (fr)
CN (1) CN1186447C (fr)
AP (2) AP2002002417A0 (fr)
AR (1) AR021450A1 (fr)
AT (1) ATE283363T1 (fr)
AU (1) AU779756B2 (fr)
BG (1) BG106478A (fr)
BR (1) BR0013093A (fr)
CA (1) CA2381427A1 (fr)
CO (1) CO5290296A1 (fr)
CZ (1) CZ2002297A3 (fr)
DE (1) DE60016231T2 (fr)
EA (1) EA004569B1 (fr)
ES (1) ES2231214T3 (fr)
GT (2) GT200000138A (fr)
HK (1) HK1046536B (fr)
HR (1) HRP20020131A2 (fr)
HU (1) HUP0202517A2 (fr)
IL (1) IL147562A0 (fr)
IS (1) IS6249A (fr)
MA (1) MA26811A1 (fr)
MX (1) MXPA02001514A (fr)
NO (1) NO20020665D0 (fr)
OA (1) OA11997A (fr)
PA (1) PA8499201A1 (fr)
PE (1) PE20010697A1 (fr)
PL (1) PL353770A1 (fr)
PT (1) PT1200605E (fr)
SK (1) SK1382002A3 (fr)
TN (1) TNSN00170A1 (fr)
UY (1) UY26287A1 (fr)
WO (1) WO2001012822A1 (fr)
YU (1) YU8402A (fr)
ZA (1) ZA200201071B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516517A (en) * 1999-08-12 2003-10-31 Pfizer Prod Inc Mutations in the aveC allele of Streptomyces avermitilis gene that reduce the ratio of cyclohexyl B2:cyclohexyl B1 avermectins
EP1474396B9 (fr) 2002-02-05 2008-07-09 Bristol-Myers Squibb Company N-substitute3-hydroxy-4-pyridinones et compositions pharmaceutiques contenant ces derniers
SI1476539T1 (sl) 2002-02-12 2009-06-30 Pfizer Prod Inc Gen streptomyces avermitilis, ki uravnava razmerje B2:B1 avermektinov
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
WO2004067549A2 (fr) * 2003-01-31 2004-08-12 Max-Delbrück-Centrum für Molekulare Medizin Peptides diriges contre des autoanticorps resultant de l'intolerance au froid, et leur utilisation
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
EP0313297B1 (fr) 1987-10-23 1993-05-19 Pfizer Inc. Procédé de production d'aglycones d'avermectine et des cultures les contenant
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
ES2079436T3 (es) 1989-03-31 1996-01-16 Merck & Co Inc Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
DK0711349T3 (da) 1993-07-30 2003-11-24 Pfizer Gener, der koder for forgrenet alfaketosyredehydrogenasekompleks fra Streptomyces avermitilis
CN1040113C (zh) * 1993-10-05 1998-10-07 美国辉瑞有限公司 抗寄生虫药物多哇麦汀(doramectin)的中间体及其制备方法
FI942725A7 (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
CA2320031A1 (fr) * 1998-02-13 1999-08-19 Pfizer Products Inc. Gene de streptomyces avermitilis commandant le rapport d'avermectines b2/b1

Also Published As

Publication number Publication date
US6509159B2 (en) 2003-01-21
ZA200201071B (en) 2003-06-25
SK1382002A3 (en) 2002-11-06
JP3688640B2 (ja) 2005-08-31
US20030124607A1 (en) 2003-07-03
YU8402A (sh) 2006-03-03
BR0013093A (pt) 2002-08-13
EP1200605A1 (fr) 2002-05-02
HRP20020131A2 (en) 2003-12-31
JP2003507018A (ja) 2003-02-25
HK1046536B (zh) 2005-05-13
MXPA02001514A (es) 2002-07-02
AR021450A1 (es) 2002-07-17
ATE283363T1 (de) 2004-12-15
US20030129636A1 (en) 2003-07-10
US6248579B1 (en) 2001-06-19
US20050196777A1 (en) 2005-09-08
KR100486006B1 (ko) 2005-05-03
HUP0202517A2 (hu) 2002-11-28
DE60016231T2 (de) 2005-12-08
IS6249A (is) 2002-01-25
AU5702100A (en) 2001-03-13
IL147562A0 (en) 2002-08-14
PE20010697A1 (es) 2001-07-05
EA004569B1 (ru) 2004-06-24
JP2005198658A (ja) 2005-07-28
US20030134313A1 (en) 2003-07-17
NO20020665L (no) 2002-02-11
US6833263B2 (en) 2004-12-21
CN1370239A (zh) 2002-09-18
HK1046536A1 (en) 2003-01-17
PA8499201A1 (es) 2001-12-14
DE60016231D1 (de) 2004-12-30
AP2002002419A0 (en) 2002-03-31
CA2381427A1 (fr) 2001-02-22
MA26811A1 (fr) 2004-12-20
EA200200057A1 (ru) 2002-06-27
CZ2002297A3 (cs) 2002-08-14
NO20020665D0 (no) 2002-02-11
PL353770A1 (en) 2003-12-01
TNSN00170A1 (fr) 2005-11-10
US7259241B2 (en) 2007-08-21
US7029887B2 (en) 2006-04-18
PT1200605E (pt) 2005-04-29
BG106478A (bg) 2004-02-27
CN1186447C (zh) 2005-01-26
US6511841B2 (en) 2003-01-28
CO5290296A1 (es) 2003-06-27
AU779756B2 (en) 2005-02-10
UY26287A1 (es) 2001-03-16
US20030129635A1 (en) 2003-07-10
ES2231214T3 (es) 2005-05-16
WO2001012822A1 (fr) 2001-02-22
AP2002002417A0 (en) 2002-03-31
KR20020022809A (ko) 2002-03-27
GT200000138A (es) 2002-02-02
US20010016350A1 (en) 2001-08-23
EP1200605B1 (fr) 2004-11-24
US20010024818A1 (en) 2001-09-27
GT200000138CA (es) 2002-02-02

Similar Documents

Publication Publication Date Title
OA11997A (en) Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins.
AU752343C (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
CA2380872C (fr) Gene de streptomyces avermitilis commandant le rapport d'avermectines b2/b1
MXPA04007777A (es) Gen de streptomyces avertmitilis que rige la relacion de avermectinas b2:b1.
AU779569B2 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
MXPA00007915A (en) I(streptomyces avermitilis) gene directing the ratio of b2:b1 avermectins